Orphan, Combo, Pediatric Products Would See More Influence In Proposed US FDA Reorg
Executive Summary
Reorganization also may force change to commissioner succession plan.
You may also be interested in...
Gottlieb Wants His US FDA Team To Stay Together After He Departs
Outgoing US FDA Commissioner Scott Gottlieb doesn't want a staff shakeup at the agency upon his departure. A look at near-term leadership strategies. Also, the wait time for confirmed commissioners has been trending down.
Gottlieb Wants His US FDA Team To Stay Together After He Departs
INFOGRAPHIC: Wait time for confirmed commissioner has been trending down.
Expanded Access: US FDA Told To Increase Regulatory Clarity, Early Interactions With Sponsors
Independent assessment finds positive perceptions of expanded access program but calls on agency to do more to correct manufacturer misperceptions about adverse events and clarify when data from expanded access would support labeling extensions.